BRAUNOVIDON
100MG/G UNG 250G I
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Cessation of marketing | 08.10.2020 |
0016319, 0016320, 0203323, 0062320 |
Switch to another pack size | |
| Interruption of marketing | 08.07.2020 |
0016319, 0016320, 0203323, 0062320 |
Capacity/distribution reasons | říjen 2020 |
| Resumption of marketing | 31.03.2020 | |||
| Interruption of marketing | 24.03.2020 |
0016319, 0016320, 0062320 |
Manufacturing reasons | 07.04.2020 |
| Resumption of marketing | 17.03.2020 | |||
| Interruption of marketing | 20.02.2020 |
0062320 |
Manufacturing reasons | 31.03.2020 |
| Interruption of marketing | 29.01.2020 |
0062320 |
Manufacturing reasons | 20.02.2020 |
| Resumption of marketing | 28.11.2019 | |||
| Interruption of marketing | 12.11.2019 |
0203323, 0062320 |
Manufacturing reasons | 16.12.2019 |
| Interruption of marketing | 06.09.2019 |
0203323, 0062320 |
Manufacturing reasons | 12.11.2019 |
| Placing on the market | 01.05.2008 |
All reports are available in the Overview.
cz